Q1 2025 Holdings
Filed 2025-05-14 | 38 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $245.7M | 3,745,262 | 18.9% |
| Verona Pharma PLC(VRNA) | SPONSERED ADS | 925050106 | $170.7M | 2,688,565 | 13.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $154.1M | 2,909,956 | 11.9% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $126.2M | 2,615,979 | 9.7% |
| Coursera Inc(COUR) | COM | 22266M104 | $85.7M | 12,867,769 | 6.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $71.5M | 11,370,376 | 5.5% |
| Savara Inc(SVRA) | COM | 805111101 | $67.8M | 24,471,264 | 5.2% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $54.0M | 1,587,854 | 4.2% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $35.7M | 7,692,298 | 2.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $31.9M | 3,969,834 | 2.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $26.7M | 3,614,486 | 2.1% |
| Cvrx Inc(CVRX) | COM | 126638105 | $24.8M | 2,026,083 | 1.9% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $20.7M | 2,613,948 | 1.6% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $19.9M | 18,093,034 | 1.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $19.0M | 1,090,793 | 1.5% |
| Neuehealth Inc | COM NEW | 10920V404 | $18.4M | 2,726,917 | 1.4% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $14.9M | 1,713,720 | 1.1% |
| Senti Biosciences Inc(SNTI) | COM NEW | 81726A209 | $12.7M | 3,775,615 | 1.0% |
| Celcuity Inc(CELC) | COM | 15102K100 | $12.6M | 1,250,001 | 1.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $12.3M | 1,960,169 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $12.3M | 2,195,545 | 0.9% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $11.3M | 6,467,802 | 0.9% |
| Desktop Metal Inc(DM*) | COM CL A | 25058X303 | $7.1M | 1,439,892 | 0.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $6.9M | 4,448,757 | 0.5% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $6.6M | 3,568,781 | 0.5% |
| Buzzfeed Inc(BZFD) | CL A NEW | 12430A300 | $5.4M | 2,512,103 | 0.4% |
| Inventiva SA(IVA) | ADS | 46124U107 | $4.3M | 1,462,586 | 0.3% |
| Synlogic Inc(SYBX) | COM NEW | 87166L209 | $3.6M | 2,922,772 | 0.3% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $3.5M | 14,986,793 | 0.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $3.4M | 17,079,778 | 0.3% |
| Inozyme Pharma Inc | COM | 45790W108 | $2.2M | 2,437,689 | 0.2% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $2.1M | 478,548 | 0.2% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $2.0M | 1,625,678 | 0.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.4M | 6,147,260 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $768.1K | 600,063 | 0.1% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $320.1K | 442,648 | 0.0% |
| Wheels UP Experience Inc(UP) | COM CL A | 96328L205 | $107.2K | 106,125 | 0.0% |
| Tuya Inc(TUYA) | SPONSERED ADS | 90114C107 | $0 | 0 | 0.0% |